Fineotex Chemical has expanded its manufacturing capacity at its Texas facility through its US subsidiary, CrudeChem Technology LLC, to meet growing demand for specialty chemicals. The expansion adds 150 million pounds per annum (MM lbs/year), increasing the plant's total output from 200 million pounds per year to 350 million pounds per year. This strategic move strengthens the company's position in the oilfield and energy sectors and enhances its North American manufacturing footprint.

Capacity Expansion at Texas Plant

The expansion significantly increases the facility's production capabilities. The following table outlines the key details of the capacity enhancement:

Strategic Significance

The expanded capacity is expected to strengthen CrudeChem Technology's position as a leading producer of specialty chemical solutions for the oilfield and energy sectors. The additional production capability will enable the company to better serve its existing customer base while supporting future growth opportunities across key markets. The expansion reflects the company's continued focus on scaling its operations, improving supply chain efficiencies, and strengthening its manufacturing footprint in North America.

Mr. Sanjay Tibrewala, Executive Director of Fineotex Chemical Limited, said, "The expansion of our manufacturing capacity at the Texas facility represents another important milestone in Fineotex growth journey. Increasing our production capacity from 200 million pounds to 350 million pounds annually significantly enhances our ability to support growing customer demand across domestic and international markets. This investment reflects our confidence in the long-term growth prospects of the specialty chemicals industry and reinforces our commitment to delivering innovative, high-quality solutions to our customers while creating sustainable value for stakeholders."

Fineotex Chemical has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board of Directors, which met on May 15, 2026, approved the results and recommended a final dividend of ₹0.05 per equity share. This dividend is subject to shareholder approval at the upcoming Annual General Meeting. For the financial year, the company reported a total dividend payout of ₹14.99 crore, compared to ₹9.17 crore in the previous year.

Consolidated Financial Performance

The company delivered robust growth in consolidated revenue and profitability for the full year. Revenue from operations for FY26 increased to ₹772.23 crore, a growth of 45% from ₹533.33 crore in FY25. Profit after tax (PAT) for the year rose by 14% to ₹125.01 crore from ₹109.21 crore in the previous year. The consolidated Return on Invested Capital (ROIC) for FY26 stood at 31.10%.

For the fourth quarter (Q4 FY26), revenue surged 162% year-on-year to ₹313.73 crore from ₹119.79 crore in Q4 FY25. PAT for the quarter increased by 118% to ₹43.80 crore from ₹20.13 crore in the corresponding period of the previous year. Operational EBITDA for the quarter grew by 86% to ₹53.15 crore from ₹28.83 crore.

The following table details the consolidated financial performance for the quarter and full year:

Operational and Corporate Updates

The company's volume growth for the consolidated business in Q4 increased by approximately 59% on a quarter-on-quarter basis and 131% on a year-on-year basis. Fineotex Chemical was recognized as a Great Place to Work for the fifth consecutive year. During the year, the Board approved a stock split of equity shares from a face value of ₹2 each to ₹1 each and a bonus issue in the ratio of 4:1. Consequently, the paid-up share capital as of March 31, 2026, stood at ₹11,645.01 lakh.

The statutory auditors, M/s. ASL & Co., Chartered Accountants, have issued an unmodified audit report on the standalone and consolidated financial results.

Management Commentary

In an earnings conference call held on May 18, 2026, management highlighted that the strong Q4 performance was driven by healthy underlying demand across three business segments, along with robust contribution from the newly acquired CrudeChem Technologies Group. International revenue contribution increased significantly to 70% in Q4 FY26. The working capital cycle remains healthy at 79 days.

Management stated that the company is in the process of doubling manufacturing capacity at CrudeChem to cater to larger contracts and accelerate growth in the high-margin specialty oilfield chemicals segment. The company targets a $200 million revenue run rate from the US business by 2028, revised from an earlier estimate of 2030, with EBITDA margins expected to reach 15%. On a consolidated level, the company aims for a blended EBITDA margin of 18% to 20%.